Canagliflozin, An SGLT2 Inhibitor, Prevents Lung Remodeling in Chronic Left Ventricular Failure
Publication/Presentation Date
2024
Volume
209
Published In/Presented At
https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A7134
Disciplines
Medicine and Health Sciences
Department(s)
Department of Surgery, Fellows and Residents
Document Type
Article
COinS
